The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
75 reports and counting
Rakuten Medical Raises $100M Series F | Photoimmunotherapy Cancer Treatment
Cancer treatment company Rakuten Medical secures $100 million Series F led by TaiAx for Phase 3 trials.
Vibrant Therapeutics Raises $61M Series B | Logic-Gated Cancer Immunotherapy
Clinical-stage biotech Vibrant Therapeutics secures $61 million Series B for tumor microenvironment-activated immunotherapies.
Treeline Biosciences Raises $421 Million in Undisclosed Round - October 17, 2024
Treeline Biosciences announced $421 Million in Undisclosed Round funding at a $1.1 Billion+ Total Raised valuation. Treeline Biosciences is a secretive biotech company focused on developing innovative cancer therapeutics using AI-powered drug discovery platforms....
AdvanCell raises $112M Series C at $700M valuation
AdvanCell raises $112M in Series C at $700M valuation. Radionuclide cancer therapies...
Artbio raises $132M Series B
Artbio raises $132M in Series B. Radiopharmaceutical company developing targeted cancer therapies...
Paige raises $45M Series C at $120M valuation
Paige raises $45M in Series C at $120M valuation. AI cancer diagnosis platform...
Star Therapeutics raises $125M Series B at $600M valuation
Star Therapeutics raises $125M in Series B at $600M valuation. Antibody therapies for cancer...
Umoja Biopharma raises $100M Series C at $800M valuation
Umoja Biopharma raises $100M in Series C at $800M valuation. Cell therapy for cancer...
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Showing 9 reports β’ Page 1 β’ Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.